Showing results (1-10 of 104) with videos related to
Sort By:
Pageof 11
Chirality|January 1, 1990
Stereoselective arylpropionyl-CoA thioester formation in vitroM P Knadler, S D HallJournal of Chromatography|September 29, 1989
High-performance liquid chromatographic analysis of the enantiomers of flurbiprofen and its metabolites in plasma and urineM P Knadler, S D HallThe Journal of Pharmacology and Experimental Therapeutics|May 1, 1989
Plasma protein binding of flurbiprofen: enantioselectivity and influence of pathophysiological statusM P Knadler, D C Brater, S D HallBritish Journal of Clinical Pharmacology|April 1, 1992
Stereoselective disposition of flurbiprofen in normal volunteersM P Knadler, D C Brater, S D HallBritish Journal of Clinical Pharmacology|April 1, 1992
Stereoselective disposition of flurbiprofen in uraemic patientsM P Knadler, D C Brater, S D HallChirality|January 1, 1992
Pulmonary inversion of 2-arylpropionic acids: influence of protein bindingS D Hall, M Hassanzadeh-Khayyat, M P Knadler, et al.Journal of Chromatography|September 2, 1992
Quantification of a decapeptide anticoagulant in rat and monkey plasma by high-performance liquid chromatographyM P KnadlerJournal of Clinical Pharmacology|August 1, 1987
Nizatidine, and H2-receptor antagonist: disposition and safety in the elderlyJ T Callaghan, A Rubin, M P Knadler, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1986
Nizatidine, an H2-blocker. Its metabolism and disposition in manM P Knadler, R F Bergstrom, J T Callaghan, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1992
Metabolism of the anticoagulant peptide, MDL 28,050, in ratsM P Knadler, B L Ackermann, J E Coutant, et al.Pageof 11